Safety and Efficacy of Targeted-Dose Busulfan and Bortezomib as a Conditioning Regimen for Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Blood Progenitor Cell Transplantation

Autor: Freytes, César O., Toro, Juan J., Yeh, Rosa F., Stadtmauer, Edward A., Ratanatharathorn, Voravit, Akpek, Görgün, Sahovic, Entezam, Tricot, Guido J., Shaughnessy, Paul J., White, Darrell J., Rodriguez, Tulio E., Solomon, Scott R., Yu, Louie H., Zhao, Cathy, Patil, Shiva, Armstrong, Elizabeth, Smith, Angela, Elekes, Agnes, Kato, Kazunobu, Reece, Donna E.
Zdroj: In Biology of Blood and Marrow Transplantation December 2014 20(12):1949-1957
Databáze: ScienceDirect